Epsilon Healthcare Ltd (ASX: EPN) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Epsilon Healthcare Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $7.21 million
P/E Ratio N/A
Dividend Yield 0.00%
Shares Outstanding 300.35 million
Earnings per share -0.011
Dividend per share N/A
Year To Date Return N/A
Earnings Yield N/A
Franking -
Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

  • Epsilon Healthcare Ltd (ASX: EPN)
    Latest News

    a woman
    Share Gainers

    Why Kogan, LiveTiles, Speedcast, & THC Global shares climbed higher today

    The LiveTiles Ltd (ASX:LVT) share price and the THC Global Group Ltd (ASX:THC) share price are two of four climbing…

    Read more »

    a woman
    Share Gainers

    Why these ASX cannabis shares are rocketing higher today

    The MGC Pharmaceuticals Ltd (ASX:MXC) share price and the THC Global Group Ltd (ASX:THC) share price are two of four…

    Read more »

    a woman
    52-Week Lows

    Why Flight Centre and these ASX shares just dropped to 52 week lows

    The Flight Centre Travel Group Ltd (ASX:FLT) share price is one of three that dropped to 52-week lows yesterday. Here’s…

    Read more »

    a woman
    Share Gainers

    Why this ASX cannabis stock has climbed 2% higher this morning

    The THC Global Group Ltd (ASX: THC) share price has climbed 2% higher in early trade after a key strategic…

    Read more »

    a woman
    Share Market News

    Here's how these ASX cannabis shares have performed in 2019

    It has been a reasonably disappointing year for AusCann Group Holdings Ltd (ASX:AC8), Cann Group Ltd (ASX:CAN), and many other…

    Read more »

    a woman
    ⏸️ Investing

    Can these ASX pot stocks deliver growth in 2019?

    Although it seems like the wind has gone out of the sails of many of the Australian-based pot stocks, I…

    Read more »

    a woman
    Share Fallers

    Cann Group Ltd (ASX:CAN) and the rest of the cannabis industry are being smoked today

    Cann Group Ltd (ASX:CAN) shares and the rest of the cannabis industry are being smoked today. Here's what you need…

    Read more »

    a woman
    Share Market News

    How did these local pot stocks react to Canada legalising cannabis?

    Canada became the second country in the world to legalise recreational weed last week, beginning a national experiment that could…

    Read more »

    a woman
    Share Gainers

    Why these cannabis shares smoked the market on Tuesday

    Cannabis shares BOD Australia Ltd (ASX:BDA), Hydroponics Company Ltd (ASX:THC), and MGC Pharmaceuticals Ltd (ASX:MXC) smoked the market on Tuesday...

    Read more »

    a woman
    ⏸️ Investing

    Are Aussie pot stocks set to smoke the market in October?

    When California started selling recreational marijuana in January, Aussie pot stocks lit up the market. Can we expect the same…

    Read more »

    a woman
    ⏸️ Investing

    Up in smoke: What happened to the ASX pot stocks?

    ASX pot stocks have taken a hit. Will they recover?

    Read more »

    a woman
    Share Market News

    Insiders have been buying these 3 ASX shares

    Sigma Healthcare Ltd (ASX:SIG) shares are one of three being snapped up by insiders this week. Here's what you need…

    Read more »

    EPN ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About Epsilon Healthcare Ltd

    Epsilon Healthcare Ltd is a diversified global healthcare and pharmaceuticals company. It owns number of medicinal cannabis assets including the cannabis manufacturing facility in the Southern Hemisphere, the Tetra Health clinic, and the Medimar Platform an end to end ecommerce solution for nutraceuticals and cannabis. EPN additionally operates a turn-key cannabis cultivation solutions provider based in Vancouver, Canada.

    Director Transactions Data provided by Morningstar.

    Data provided by Morningstar.
    Date Director Type Amount Value Notes
    28 Sep 2023 Alan Beasley Buy 50,000 $1,563
    On-market trade.
    22 Sep 2023 Alan Beasley Buy 2,543,822 $67,433
    On-market trade.
    21 Sep 2023 Alan Beasley Buy 3,300,000 $85,800
    Off-market trade.
    12 Sep 2023 Alan Beasley Buy 1,931,156 $47,200
    On-market trade.
    30 Jun 2023 Alan Beasley Buy 2,675,022 $54,984
    On-market trade.

    Directors & Management Data provided by Morningstar.

    Data provided by Morningstar.
    Name Title Start Date Profile
    Mr Stuart Hamilton Cameron Non-Executive Director Oct 2022
    Stuart is a Chartered Accountant having many years of experience dealing with listed public companies.
    Mr Alan Preston Beasley Non-Executive DirectorNon-Executive Deputy Chairman Aug 2016
    Mr Beasley has worked in the Investment Banking and Investment Management Industries for over 30 years with BankersTrust Australia, Goldman Sacks Asset Management, BNP Paribas Asset Management Ltd. The last two positions as Managing Director and Australian Country Head. Mr Beasley is a Director and former Director of several listed and unlisted public and private companies including two public charities.
    Mr Xiao (Josh) Cui Executive ChairmanExecutive Director Oct 2022
    Mr Cui is the Managing Director at Watercrest Capital, a global private investment firm specialising in managing alternative investments and dealing with multiple asset classes. Mr Cui manages private equity, energy resources, hedge funds, fixed income, forex exchange and real estate development. He currently holds an RG 146 Forex certificate and The Securities Qualification Certificate from SAC. Adiitionally, he has 10 years of experience as a professional investor specialising in generating investment returns by leveraging flexible investment strategies. He has been focused on primary market capital raising and PE investment not just in Australia, but also the Asia Pacific area. He also has experience in primary/secondary market investments, hedge fund and other entities, capital market fund raising, IPO and M&A.
    Mr Marcelo Mora Company Secretary Dec 2022
    -
    Mr Peter Giannopoulos Chief Executive Officer May 2023
    -
    Peter Giannopoulos Chief Executive Officer
    -
    Marcelo Mora Company Secretary
    -

    Top Shareholders Data provided by Morningstar.

    Data provided by Morningstar.
    Name Shares Capital
    Watercrest Asset Management Pty Ltd 35,828,878 11.93%
    Fennell Church Pty Ltd 8,438,499 2.81%
    Mr Craig Graeme Chapman <Nampac Discretionary A/C> 7,500,000 2.50%
    Health360 Investment Management Inc 7,052,880 2.35%
    Cannim Group Pty Ltd 5,555,556 1.85%
    Filmrim Pty Ltd 4,465,755 1.49%
    Barcoo Holdings Pty Ltd <Wyan Family Investments> 3,795,824 1.26%
    Karantzias Investments Pty Ltd <Karantzias Family A/C> 3,636,364 1.21%
    Sckld Investments Pty Ltd <Sckld Holdings A/C> 3,593,894 1.20%
    Bnp Paribas Nominees Pty Ltd <Ib Au Noms Retailclient Drp> 3,055,650 1.02%
    Mr George Daaboul 3,000,000 1.00%
    Meta Growth Corp 2,942,489 0.98%
    Celtic Capital Pty Ltd 2,888,872 0.96%
    Tiger Pty Ltd <Tiger Commercial Unit Trust> 2,545,455 0.85%
    Barcoo Holdings Pty Ltd <Maple Ventures> 2,438,341 0.81%
    Htgr Investments Pty Ltd 2,298,765 0.77%
    Mrs Chongna Wang 2,046,035 0.68%
    Mr Alan Roseby Barkas + Mrs Lee Margaret Barkas <Barkas Super 2,000,000 0.67%
    Mr Craig Graeme Chapman <Nampac Discretionary A/C> (i) 1,958,684 0.65%
    Citicorp Nominees Pty Limited 1,598,988 0.53%

    Profile

    since

    Note